ÂÜÀòÂÒÂ×

Dr. Peter Christalla possesses extensive experience in global business development and licensing within the pharmaceutical and biotechnology sectors, currently serving as Senior Manager at STADA Group and Senior Manager at Fresenius Kabi. Prior roles include Project Manager in Cardiac Cell Therapeutics at Miltenyi Biotec GmbH and Team Leader at the University Medical Center Goettingen. Academic qualifications include a PhD in Molecular Biology and Pharmacology from the University Medical Center Hamburg-Eppendorf and a Business Economist degree from FernUniversität in Hagen. Expertise encompasses regenerative medicine, cardiac tissue engineering, biomaterials, stem cell technology, and proteomics.